Treatment of Hyperlipidemias Flashcards

1
Q

high molecular weight complexs of specific proteins and lipids, that transport triglycerides and cholesterol in the blood

A

lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hyperlipidemias can lead to acute ______ (if triglycerides >1,000) and atherosclerosis

A

pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • 4 major group of lipoproteins: chylomicrons, VLDL, LDL, HDL
  • in general, ____ dense lipoproteins contain more triglyceride
A

larger, less dense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

chylomicrons synthesized in the ______ transport dietary lipids into circulation, 20% of body’s cholesterol comes from food

A

enterocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

VLDL synthesized in _______ transports fatty acids and cholesterol to peripheral tissues, account for 80% of body’s cholesterol

A

hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

VLDL is converted to ______ by further removal of ________ mediated by hepatic lipase, then catabolized in hepatocytes by receptor mediate endocytosis

A

LDL

triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

_____ is responsible for transfer of cholesterol and apoliporporteins to the liver

A

HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

elevated _____ is a major risk factor for atherosclerosis, any that is not taken up by hepatic receptors migrate into vascular intima

A

LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

____ synthesized by liver and intestine decreased amt of cholesterol available for tissue deposition by removing it from macrophages and promoting its return to the liver

A

HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • high triglycerides (200-500)
  • familial of unknown genetic cause
  • fibrates are drug of choice
  • rarly have familial lipoprotein lipase deficiency or apoCII deficiency
A

primary hypertriglyceridemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • high cholesterol (260-500) with normal triglycerides
  • familial: defects in LDL receptor, elevated cholesterol from birth, responds well to statins
  • familial defective apoB100: decreased aff to LDL receptor
  • polygenic
A

primary hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • complex lipid profile: elevated total cholesterol, LDL, triglycerides, reduced HDL
  • familial combined: obesity, glucose intolerance, HTN, require statins
  • dysbetalipoproteinemia: defect in apoE, increased chylomicrons and IDL like particles, treat with niacin and fibrates
A

mixed hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

decision to treat cholesterol levels is based on?

A

risk of CV disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

-statins are what drug class?

A

HMG-CoA reductase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

nicotinic acid, vitamin B3 are what class?

A

niacins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

gemfibrozil and fenofibrate?

A

fibric acid derivatives

17
Q

colestipol, cholestyramine, colesevelam?

A

bile acid binding resins

18
Q

ezetimibe?

A

intestinal sterol absorption inhibitor

19
Q
  • statins inhibit HMGCoA reductase to reduce hepatic formation of cholesterol and increase _________ in hepatocytes to lower plasma LDL
  • decrease plasma triglycerides and increase HDL cholesterol
  • prodrugs: ?
  • active: atorvastatin, fluvastatin, rosuvastatin, and pravastatin
  • GI absorption is almost complete for fluvastatin
  • all have high _____ metabolism and mostly excreted in ______
A

LDL receptors

lovastatin, simvastatin

first pass hepatic

bile

20
Q

statins are first line therapy for elevated _____ levels, significantly reduce mortality from MI and in CVD patients at high risk, best given at night when _______ occurs, contraindicated in pregnancy

A

LDL

cholesterol synthesis

21
Q
  • statin toxicity indicated by elevations in serum _______
  • macrolides, cyclosporine, ketoconazole, fibrates, grapefruit juice, phenytoin, rifampin, amiodarone inhibit or compete for CYP enzymes
A

aminotransaminase

22
Q

______ not metabolized by P450, preferred in combo with other drugs

A

pravastatin

23
Q

statins: increased ________ activity indicates skeletal muscle toxicity occurring as rhabdomyolysis

A

creatine kinase

24
Q

_____ may enhance the myopathic effect of statins

A

gemfibrozil

25
Q
  • water soluble vitamin converted to amide, incorporated into NAD and excreted in urine
  • decreases lipase activity in adipose tissues, reduce FFA flux to liver, decrease synthesis of triglycerides and VLDL, lower plasma LDL and triglycerides
  • drug of choice for patients with elevated LDL and lowered HDL
  • toxicity: cutaneous flushing, due to PGs, reduced w/ aspiring, increased uric acid and fasting glucose
A

niacin (B3, nicotinic acid)

26
Q
  • ligands for PPAR-alpha in hepatocytes
  • decrease plasma triglycerides, VLDL, LDL, increase plasma HDL
  • used for treatment of hypertriglyceridemia and dysbetalipoproteinemia
  • skin rash, hypokalemia, decrease in WBC
  • avoid in renal or hepatic dysfunction, risk of myopathy with statins, risk for cholesterol gallstones
A

fibric acid derivatives - gemfibrozil and fenofibrate

27
Q
  • found in fish oils
  • activate PPARalpha
  • profound reduction of triglycerides
A

omega 3 fatty acids

28
Q
  • large cationic exchange resins, insoluble in water
  • bind bile acids and increase excretion
  • 7a-hydroxylase upregulated, for synthesis of bile acids from cholesterol
  • increased bile acid synthesis = reduced amt of heptic cholesterol
  • increases LDL receptors, enhances removal from circulation
  • lowers plasma LDL and elevates plasma HDL
A

bile acid binding resins: colestipol, cholestyramine, colesevelam

29
Q
  • used for primary hypercholesterolemia
  • might increase VLDL
  • digoxin toxicity
  • possibly decreased absorption of fat soluble vitamins, bloating and constipation
A

bile acid binding resins

30
Q
  • inhibits intestinal absorption of cholesterol and phytosterols
  • reduces plasma LDL and minimal increase in HDL
  • for treatment of primary hypercholesterolemia
  • low incidence of reversible hepatic impairment
A

eztimibe

31
Q

drug combos when:

  • VLDL levels increasing during ____ therapy of hypercholesterolemia
  • VLDL and LDL both elevated, or not normalized by single drug
  • ____ deficiency with other hyperlipidemias
A

resin

HDL